BEIJING, Nov. 14 (Xinhua) According to CCTV "News 30" report, the NDRC price supervision and inspection and anti-monopoly bureau out huge fines, Shandong Weifang Pharmaceutical Co., Ltd. and Shun Weifang Huaxin Pharmaceutical Trading Co., Ltd., since the control compound reserpine raw materials, forcing producers to raise downstream tender price, seriously undermining the national drug price bidding system. According to antitrust regulations, confiscate the illegal income and impose a fine of 6.877 million yuan and 152,600 yuan total. It is reported that the case led to heavy penalties from the monopoly case.

It is reported that compound reserpine is included in the National Essential Drugs List of anti-hypertensive drugs, each piece of the retail price of only 0.08 yuan, the country currently has more than 10 million hypertensive patients rely on this drug, and mainly low-income groups, The annual consumption of about 80-90 one hundred million. The main raw material for compound reserpine promethazine hydrochloride, currently only Liaoning Province Dandong Donggang Hongda Pharmaceutical Co., Ltd. and Yichuang Pharmaceutical limited liability company.

Verified by the Antitrust Division of the NDRC, June 9, 2011, Shandong Province and Liaoning Province Shun HTC, Shandong Province, China and Liaoning Yichuang new product sales agent agreements were signed, monopolizing all of promethazine hydrochloride in the domestic sales . According to the Anti-Monopoly Bureau of the NDRC, Jiang said that the signing of this agreement, the first one is that the two companies were the exclusive sales agent of these two manufacturers of promethazine hydrochloride promethazine hydrochloride produced raw materials, and the second is expressly agreed that the two home promethazine hydrochloride production enterprises in Shandong two companies without the authorization shall not be shipped to a third party.

Changzhou Pharmaceutical Factory, Asia treasure liquid, Connaught medicine, Xinhua Pharmaceutical Company is China's production of compound reserpine maximum four companies, the market share of more than 75% of the country, this four companies can not buy from the original sources isoproterenol hydrochloride triazine. Shandong two companies in this four business negotiation, which means that you can provide promethazine hydrochloride, but four companies must first compound reserpine in price from 1.3 yuan / bottle raised to 5 yuan / bottle -6 yuan / bottle. NDRC said that Shandong Weifang Pharmaceutical Co., Ltd. and Shun Weifang Huaxin Pharmaceutical Trading Co. forced downstream production enterprises to raise the tender price, seriously undermining the national drug price bidding system. According to antitrust regulations, confiscate the illegal income and impose a fine of 6.877 million yuan and 152,600 yuan total. (BEIJING Finance Channel)